Reducing the Duration of Untreated Psychosis in the United States
Early Stage Identification and Engagement to Reduce Duration of Untreated Psychosis (EaSIE)
2 other identifiers
observational
94
1 country
3
Brief Summary
The goal of this project is to investigate whether a systematic screening approach for individuals with first episode psychosis (FEP) can substantially reduce Duration of Untreated Psychosis (DUP). The study team will evaluate the feasibility of screening a consecutive help-seeking population entering mental health services in order to facilitate early identification of FEP cases, rapid referral to specialty care and engagement in treatment.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Feb 2018
Typical duration for all trials
3 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 6, 2017
CompletedFirst Posted
Study publicly available on registry
December 12, 2017
CompletedStudy Start
First participant enrolled
February 19, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 15, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
September 15, 2021
CompletedDecember 14, 2021
December 1, 2021
3.6 years
December 6, 2017
December 10, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Duration of Untreated Psychosis (DUP)
The DUP is defined as the time, in weeks, between onset of psychotic symptoms and initiation of FEP treatment, in the case of this study, entry into Coordinated Specialty Care (CSC) programs for first episode psychosis (FEP).
Day 1
Secondary Outcomes (5)
Rate of completed PQ-B screen.
Day 1
Rate of completed SIPS
Day 1
Rates of FEP cases
Day 1
Rate of ARMS cases
Day 1
Rate of CHR cases
Day 1
Eligibility Criteria
Individuals ages 12 to 30 entering child/adolescent and adult community mental health clinics.
You may qualify if:
- age 12- 30
- ability to participate in assessments in English
- ability to provide informed consent (assent for those under age 18)
- meet criteria for psychosis or psychosis risk on SIPS
You may not qualify if:
- previous diagnosis of schizophrenia or schizoaffective disorder.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (3)
Trustees of Boston University
Boston, Massachusetts, 02215, United States
Research Foundation/City University of New York (CUNY) on behalf of CUNY Graduate School
New York, New York, 10027, United States
Icahn School of Medicine at Mount Sinai
New York, New York, 10029, United States
Related Publications (3)
Addington J, Heinssen RK, Robinson DG, Schooler NR, Marcy P, Brunette MF, Correll CU, Estroff S, Mueser KT, Penn D, Robinson JA, Rosenheck RA, Azrin ST, Goldstein AB, Severe J, Kane JM. Duration of Untreated Psychosis in Community Treatment Settings in the United States. Psychiatr Serv. 2015 Jul;66(7):753-6. doi: 10.1176/appi.ps.201400124. Epub 2015 Jan 15.
PMID: 25588418BACKGROUNDDixon LB, Goldman HH, Bennett ME, Wang Y, McNamara KA, Mendon SJ, Goldstein AB, Choi CW, Lee RJ, Lieberman JA, Essock SM. Implementing Coordinated Specialty Care for Early Psychosis: The RAISE Connection Program. Psychiatr Serv. 2015 Jul;66(7):691-8. doi: 10.1176/appi.ps.201400281. Epub 2015 Mar 16.
PMID: 25772764BACKGROUNDRietdijk J, Klaassen R, Ising H, Dragt S, Nieman DH, van de Kamp J, Cuijpers P, Linszen D, van der Gaag M. Detection of people at risk of developing a first psychosis: comparison of two recruitment strategies. Acta Psychiatr Scand. 2012 Jul;126(1):21-30. doi: 10.1111/j.1600-0447.2012.01839.x. Epub 2012 Feb 15.
PMID: 22335365BACKGROUND
Study Officials
- PRINCIPAL INVESTIGATOR
Yulia Landa, PsyD, MS
Icahn School of Medicine at Mount Sinai
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor
Study Record Dates
First Submitted
December 6, 2017
First Posted
December 12, 2017
Study Start
February 19, 2018
Primary Completion
September 15, 2021
Study Completion
September 15, 2021
Last Updated
December 14, 2021
Record last verified: 2021-12
Data Sharing
- IPD Sharing
- Will share
In accordance with NIH policy, a de-identified dataset will be uploaded to the NIMH Data Archive: the National Database for Clinical Trials Related to Mental Illness.